TIDMCRDA
RNS Number : 6415B
Croda International PLC
11 January 2018
11 January 2018
Croda International plc ('Croda' or 'the Company')
Technology acquisitions
Croda International Plc, who make, create and sell innovative
and sustainable speciality chemicals for some of the biggest, most
successful brands in the world, has completed two technology
acquisitions in exciting and novel application areas. This brings
the number of technology acquisitions and co-investments completed
in the last 12 months to four. Croda's technology acquisition
programme supplements its development of new opportunities through
organic investment and open innovation.
Nautilus Biosciences Canada Inc ('Nautilus'), is a
technology-rich marine biotechnology company based in
Charlottetown, Canada. Founded in 2007, Nautilus focuses on using
marine microbial biodiversity to discover novel actives and
materials. Through this acquisition and the associated patents,
Croda will utilise this innovative science for applications across
all its market sectors.
Croda and Nautilus already have a proven history of successful
collaboration, having worked closely together for the past six
years developing specific applications for skin care and hair care,
as well as crop care. Croda intends to establish Nautilus as a
Croda centre of innovation for Marine Biotechnology at Nautilus'
existing base at the University of Prince Edward Island. This
location is ideal for biotechnology research and has already
attracted and facilitated partnerships with many other
biotechnology-based companies. Nautilus has exclusive global access
to the Marine Microbial Library which is based at the University of
Prince Edward Island.
Croda has also completed the acquisition of IonPhasE Oy
('IonPhasE'), an innovative technology supplier of static
electricity protection products, headquartered in Tampere,
Finland.
Operating in some of the fastest growing segments within the
plastics market, IonPhasE has developed a unique range of
anti-static additives that help to prevent damage to electrical
components, increase the safety of chemical and food packaging and
improve the long-term appearance of consumer appliances. Focused on
Electrostatic Discharge Protection (ESD) and Inherently Dissipative
Polymers (IDPs), IonPhasE's products use the most advanced
technologies in the static electricity protection market, which
work to release static electricity in a controlled way.
These acquisitions follow the purchase of Enza Biotech AB in
July 2017, a research enterprise in Sweden aiming to develop the
next generation of renewable surfactants, together with an
investment in Cutitronics Limited, a UK technology based innovator
of personalised, adaptive skin care. These additional technology
acquisitions support Croda's growth strategy within high
technology, consumer driven markets, through exciting science-rich
opportunities.
Steve Foots, Chief Executive of Croda, said: "These acquisitions
are very much aligned to our strategy of investing in disruptive
technologies, clever people and rich intellectual property. With
Nautilus as part of the Croda group, we further expand our
expertise in biotechnology; the Nautilus team that will join us
have extensive knowledge and expertise in marine biotechnology,
also known as "blue biotechnology". The experience and knowledge of
the IonPhasE management team, coupled with our innovation strength,
global sales reach and complementary technologies, will allow us to
better meet the needs of our customers within our Smart Materials
business within the Performance Technologies sector."
For enquiries contact:
Conleth Campbell, Head of Investor Relations: 01405 860551
Teneo Blue Rubicon: Charlie Armitstead: 020 3603 5220
About Croda - www.croda.com
Established in 1925, Croda is the name behind high performance
ingredients and technologies in some of the world's biggest and
most successful brands: creating, making and selling speciality
chemicals that are relied on by industries and consumers
everywhere.
They have a network of over 4,200 passionate and committed
employees, working together as one global team across manufacturing
sites and offices in 36 countries. Croda is a FTSE100 company with
a flexible structure that allows them to focus on developing and
delivering innovative, sustainable ingredients that their customers
can build on in: Personal Care, Health Care, Crop Care, Polymer
Additives, Lubricants, Coatings & Polymers, Geo Tech, Home Care
and Industrial Specialities.
About Nautilus - www.nautilusbiosci.net
Nautilus Biosciences Canada is a marine biotechnology company
located on the University of Prince Edward Island campus in
Charlottetown, PEI. It aims to discover and develop bioactive
agents from a marine microbial collection with applications focused
on health and wellness.
About IonPhasE - www.ionphase.fi
Established in 2001, Finnish technology company IonPhasE is a
leading manufacturer of static dissipative polymer additives,
commonly known as permanent antistatic additives. These additives
are used to control static electricity in plastics, which is
utilised in wide range of global markets including electronics and
semiconductor, chemical, food, automotive and consumer
appliances.
About Enza Biotech - www.enzabiotech.com
Enza Biotech was founded in 2012 as a private spin-off company
based on the results of a research programme coordinated by Lund
University. A small, but highly innovative company, they combine
insight into industrial challenges with a molecular understanding
and knowledge of biotechnology based production methods.
The collaboration between biotechnology researchers and material
scientists resulted in the design of a production process for a
completely novel type of surfactant that meets the needs of many
different markets.
About Cutitronics - www.cutitronics.com
Cutitronics is a multi-award winning technology company
strategically white-labelling patented platforms and devices for
global premium skin care brands in order to enhance consumer
skincare routines through intelligent product application.
Cutitronics was spun-out of the University of Strathclyde in
January 2014 by founder Dr David Heath and is located in Scottish
Enterprise Technology Park, East Kilbride.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACQFKDDQBBKDFDD
(END) Dow Jones Newswires
January 11, 2018 08:00 ET (13:00 GMT)
Croda (LSE:CRDA)
Historical Stock Chart
From Apr 2024 to May 2024
Croda (LSE:CRDA)
Historical Stock Chart
From May 2023 to May 2024